标题:POTENTIAL APPLICATION VALUE OF CONTRAST-ENHANCED ULTRASOUND IN NEOADJUVANT CHEMOTHERAPY OF BREAST CANCER
作者:Cao, Xiaoli; Xue, Jie; Zhao, Bin
作者机构:[Cao, Xiaoli; Zhao, Bin] Shandong Univ, Sch Med, Shandong Med Imaging Res Inst, Jinan 250021, Shandong, Peoples R China.; [Cao, Xiaoli; Xue, Jie] Ya 更多
通讯作者:Zhao, B
通讯作者地址:[Zhao, B]Shandong Univ, Sch Med, Shandong Med Imaging Res Inst, 44 Wenhua Xi Rd, Jinan 250021, Shandong, Peoples R China.
来源:ULTRASOUND IN MEDICINE AND BIOLOGY
出版年:2012
卷:38
期:12
页码:2065-2071
DOI:10.1016/j.ultrasmedbio.2012.07.027
关键词:Breast cancer; Doppler ultrasound; Ultrasound contrast media;; Neoadjuvant chemotherapy
摘要:The purpose of this study was to investigate the value of contrast-enhanced ultrasound (CEUS) in evaluating the response of breast cancer to neoadjuvant chemotherapy (NAC). The study included 31 breast cancer patients who were treated with NAC between August 2010 and October 2011. All patients were evaluated by both conventional ultrasound (US) and CEUS. The tumor sizes measured by CEUS were larger and more accurately imaged than those evaluated by US. Necrosis at the tumor center could be detected by CEUS, which showed a local blood perfusion defect in 26 cases (83.9%) before NAC and 27 cases (87.1%) after NAC, whereas US did not show liquefaction in any patient. The CEUS time-intensity curve displayed quantitatively the tumors' blood-perfusion changes; after NAC, blood perfusion reduced, enhancement intensity decreased, time to peak increased, peak intensity reduced, and the wash-in slope reduced (p < 0.05). Overall, the CEUS is a promising tool for evaluating the response of breast cancer to NAC. (E-mail: cjr.zhaobin@vip.163.com and cxl969@sina.com) (c) 2012 World Federation for Ultrasound in Medicine & Biology.
收录类别:EI;SCOPUS;SCIE
WOS核心被引频次:19
Scopus被引频次:19
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84870293441&doi=10.1016%2fj.ultrasmedbio.2012.07.027&partnerID=40&md5=44d84ff4b500ff46aa22663eda5b3748
TOP